116
Participants
Start Date
December 4, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
Placebo
Placebo contains no active substance.
TQA3334 Tablet
Inhibit viral replication.
Nucleoside (acid) analogs (NAs)
Inhibit viral replication.
The Sixth People's Hospital of Shenyang, Shenyang
The first hospital of Jilin University, Changchun
The Fifth People's Hospital of Wuxi (Affiliated Wuxi Fifth Hospital of Jiangnan University), Wuxi
People's Hospital Of RuiAn City, Rui’an
The First Affiliated Hospital of Chongqing Medical University, Chongqing
The Second XIANGYA Hospital Of Central South University, Changsha
WuHan Jinyintan Hospital, Wuhan
The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou
Peking University Shenzhen Hospital, Shenzhen
Hospital workers in Liuzhou, Liuzhou
West China Hospital of Sichuan University, Chengdu
First People's Hospital of Yunnan Province, Kunming
Pu'er People's Hospital, Pu'er
The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an
The First Affiliated Hospital of Xinjiang Medical University, Ürümqi
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY